Synonyms: Actimmune®. | IFNγ2a
IFN-γ1b (human recombinant) is an approved drug (FDA (1999))
Compound class:
Peptide
Comment: This is a recombinant analogue of human interferon gamma (IFN-γ) produced in E.coli and is therefore not glycosylated.
|
References |
1. Boehm U, Klamp T, Groot M, Howard JC. (1997)
Cellular responses to interferon-gamma. Annu Rev Immunol, 15: 749-95. [PMID:9143706] |
2. Key Jr LL, Rodriguiz RM, Willi SM, Wright NM, Hatcher HC, Eyre DR, Cure JK, Griffin PP, Ries WL. (1995)
Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med, 332 (24): 1594-9. [PMID:7753137] |
3. No authors listed. (1991)
A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med, 324 (8): 509-16. [PMID:1846940] |
4. Seyer L, Greeley N, Foerster D, Strawser C, Gelbard S, Dong Y, Schadt K, Cotticelli MG, Brocht A, Farmer J et al.. (2015)
Open-label pilot study of interferon gamma-1b in Friedreich ataxia. Acta Neurol Scand, 132 (1): 7-15. [PMID:25335475] |
5. Tau G, Rothman P. (1999)
Biologic functions of the IFN-gamma receptors. Allergy, 54 (12): 1233-51. [PMID:10688427] |